Weill Medical College of Cornell University
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
Breast Cancer
Live Biobank
To test this hypothesis the investigators will focus on studying BC patients using an innovative approach, the DIGNITY Study (De-convoluting interactions between genes, the cancer environment, and the immune system to develop therapies that work for you) designed to building a live tissue biobank of Patient Derived Tumor Organoids (PDOs) derived from tumor at surgery, preceded or not by neoadjuvant therapy (NAT), and at recurrence/metastasis. BC patients enrolled in this study are consented to enable investigators to generate a biobank of tumor tissue (obtained from surgically removed excess that would otherwise be disposed off ) and matched blood cells ( obtained from an already existing line or a venipuncture ordered per standard of care testing) at key timepoints in their treatment course.}}
| Study Type : | Observational |
| Estimated Enrollment : | 400 participants |
| Official Title : | De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
| Actual Study Start Date : | January 12, 2022 |
| Estimated Primary Completion Date : | December 31, 2027 |
| Estimated Study Completion Date : | December 31, 2028 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 90 Years |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Brooklyn Methodist Hospital - NewYork Presbyterian
New York, New York, United States, 11215
Recruiting
New York Presbyterian Hospital - Queens
New York, New York, United States, 11355